Press Release

DTL Aims for ‘Consistent, Reliable’ Cannabis Therapies for Parkinson’s

Day Three Labs, known as DTL, is launching an initiative to develop “consistent, reliable and repeatable” cannabis-based therapies for people with Parkinson’s disease. The work will be funded by CanNegev, a cannabis innovation incubator sponsored by the government of Israel.  “Parkinson’s Disease and other neuro-degenerative diseases have been notoriously difficult to treat, and the pharmaceutical industry has …

DTL Aims for ‘Consistent, Reliable’ Cannabis Therapies for Parkinson’s Read More »

Day Three Labs Poised to Deliver First Ingestible Cannabinoid Remedy for Parkinson’s with Unlokt™

Israeli Government Backed Organization, CanNegev, to Fund Research and Innovation from Day Three Labs to Relieve Parkinson’s Symptoms in Patients and Stop the Progression of the Disease DENVER and JERUSALEM, July 19, 2022 /PRNewswire/ — Day Three Labs (DTL), developer of Unlokt™, the first proven novel protein delivery technology disrupting the way edibles are developed, delivered and consumed, today announced …

Day Three Labs Poised to Deliver First Ingestible Cannabinoid Remedy for Parkinson’s with Unlokt™ Read More »

Colorado Company To Research Cannabis As A Treatment For Parkinson’s Disease

A.J. Herrington Colorado-based Day Three Labs announced this week that the world’s first government-sponsored cannabis technology incubator will fund the company’s research into using cannabis as a treatment for Parkinson’s disease.  Day Three labs is a cannabinoid consumer products ingredient manufacturer specializing in the development and commercialization of novel cannabis products with its headquarters in …

Colorado Company To Research Cannabis As A Treatment For Parkinson’s Disease Read More »

Olio Live Edibles Launch with Live Rosin and Novel Protein Technology for a Delivery Model that Unlocks Effects Familiar to Flower Enthusiasts

DENVER, July 12, 2022–(BUSINESS WIRE)–Olio, Colorado’s leading cannabis extraction brand, and Day Three Labs, a cannabinoid CPG ingredient manufacturer, today announced the launch of Olio Live Edibles with Unlokt™ by Day Three Labs. The groundbreaking new product line marks the first time single-strain, fresh-frozen cannabis hash is combined with a pharmaceutical-grade infusion technology for an all-natural, …

Olio Live Edibles Launch with Live Rosin and Novel Protein Technology for a Delivery Model that Unlocks Effects Familiar to Flower Enthusiasts Read More »

Day Three Labs Acquires Pharma-Grade Cannabinoid Infusion Technology In Deal Led By KEY Investment Partners

Cannabinoid CPG ingredient producer Day Three Labs (DTL) revealed Tuesday that it has acquired a patented pharmaceutical-grade cannabinoid infusion technology developed by a leading Israeli bioscience company. This first-of-its-kind technology allows ingested cannabinoids to naturally bypass patients’ and consumers’ first-pass metabolism, delivering significantly elevated levels of Delta 9-THC into the bloodstream without converting to 11-hydroxy-THC. As a result, DTL’s technology is able …

Day Three Labs Acquires Pharma-Grade Cannabinoid Infusion Technology In Deal Led By KEY Investment Partners Read More »